SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-026086
Filing Date
2023-06-02
Accepted
2023-06-02 16:21:11
Documents
13
Period of Report
2023-05-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kura-20230531.htm   iXBRL 8-K 106509
2 EX-99.1 kura-ex99_1.htm EX-99.1 503047
  Complete submission text file 0000950170-23-026086.txt   796410

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kura-20230531_pre.xml EX-101.PRE 11126
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kura-20230531.xsd EX-101.SCH 2486
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kura-20230531_lab.xml EX-101.LAB 17944
7 EXTRACTED XBRL INSTANCE DOCUMENT kura-20230531_htm.xml XML 4709
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37620 | Film No.: 23989099
SIC: 2834 Pharmaceutical Preparations